Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Autoantibodies against type I IFNs in patients with critical influenza pneumonia
Qian Zhang, Andrés Pizzorno, Lisa Miorin, et al.
The Journal of Experimental Medicine (2022) Vol. 219, Iss. 11
Open Access | Times Cited: 74

Showing 1-25 of 74 citing articles:

From rare disorders of immunity to common determinants of infection: Following the mechanistic thread
Jean‐Laurent Casanova, Laurent Abel
Cell (2022) Vol. 185, Iss. 17, pp. 3086-3103
Open Access | Times Cited: 101
Autoantibodies against type I IFNs in humans with alternative NF-κB pathway deficiency
Tom Le Voyer, Audrey V. Parent, Xian Liu, et al.
Nature (2023) Vol. 623, Iss. 7988, pp. 803-813
Open Access | Times Cited: 57
Autoantibodies neutralizing type I IFNs underlie West Nile virus encephalitis in ∼40% of patients
Adrian Gervais, Francesca Rovida, Maria Antonietta Avanzini, et al.
The Journal of Experimental Medicine (2023) Vol. 220, Iss. 9
Open Access | Times Cited: 54
Unlocking life-threatening COVID-19 through two types of inborn errors of type I IFNs
Jean‐Laurent Casanova, Mark S. Anderson
Journal of Clinical Investigation (2023) Vol. 133, Iss. 3
Open Access | Times Cited: 40
Higher COVID-19 pneumonia risk associated with anti-IFN-α than with anti-IFN-ω auto-Abs in children
Paul Bastard, Adrian Gervais, Maki Taniguchi, et al.
The Journal of Experimental Medicine (2024) Vol. 221, Iss. 2
Open Access | Times Cited: 22
Human autoantibodies neutralizing type I IFNs: From 1981 to 2023
Paul Bastard, Adrian Gervais, Tom Le Voyer, et al.
Immunological Reviews (2024) Vol. 322, Iss. 1, pp. 98-112
Open Access | Times Cited: 20
The ouroboros of autoimmunity
Jean‐Laurent Casanova, Jessica N. Peel, Jean Donadieu, et al.
Nature Immunology (2024) Vol. 25, Iss. 5, pp. 743-754
Closed Access | Times Cited: 16
Transfer of IgG from Long COVID patients induces symptomology in mice
Hung‐Jen Chen, Brent Appelman, Hanneke L.D.M. Willemen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 14
Multiomics dissection of human RAG deficiency reveals distinctive patterns of immune dysregulation but a common inflammatory signature
Marita Bosticardo, Kerry Dobbs, Ottavia M. Delmonte, et al.
Science Immunology (2025) Vol. 10, Iss. 103
Closed Access | Times Cited: 1
Interfering with Interferons: A Critical Mechanism for Critical COVID-19 Pneumonia
Helen C. Su, Huie Jing, Yu Zhang, et al.
Annual Review of Immunology (2023) Vol. 41, Iss. 1, pp. 561-585
Open Access | Times Cited: 31
Innate immunity and interferon in SARS-CoV-2 infection outcome
Ram Savan, Michael Gale
Immunity (2023) Vol. 56, Iss. 7, pp. 1443-1450
Open Access | Times Cited: 25
Autoantibodies targeting type I interferons: Prevalence, mechanisms of induction, and association with viral disease susceptibility
Benjamin G. Hale
European Journal of Immunology (2023) Vol. 53, Iss. 6
Open Access | Times Cited: 21
Role of IL-27 in Epstein–Barr virus infection revealed by IL-27RA deficiency
Emmanuel Martin, Sarah Winter, Cécile Garcin, et al.
Nature (2024) Vol. 628, Iss. 8008, pp. 620-629
Closed Access | Times Cited: 12
Human life within a narrow range: The lethal ups and downs of type I interferons
Yanick J. Crow, Jean‐Laurent Casanova
Science Immunology (2024) Vol. 9, Iss. 97
Closed Access | Times Cited: 12
Defining the balance between optimal immunity and immunopathology in influenza virus infection
Thi H. O. Nguyen, Louise C. Rowntree, Brendon Y. Chua, et al.
Nature reviews. Immunology (2024) Vol. 24, Iss. 10, pp. 720-735
Closed Access | Times Cited: 10
The Microbe, the Infection Enigma, and the Host
Jean‐Laurent Casanova, Laurent Abel
Annual Review of Microbiology (2024) Vol. 78, Iss. 1, pp. 103-124
Closed Access | Times Cited: 8
Loss of tolerance precedes triggering and lifelong persistence of pathogenic type I interferon autoantibodies
Sonja Fernbach, Nina K. Mair, Irène A. Abela, et al.
The Journal of Experimental Medicine (2024) Vol. 221, Iss. 9
Open Access | Times Cited: 8
Mechanisms of antibody-dependent enhancement of infectious disease
Timothy J. Wells, Tyron Esposito, Ian R. Henderson, et al.
Nature reviews. Immunology (2024)
Closed Access | Times Cited: 7
Anti-GM-CSF Neutralizing Autoantibodies in Colombian Patients with Disseminated Cryptococcosis
Carlos A. Arango-Franco, Mélanie Migaud, Isabel Cristina Ramírez‐Sánchez, et al.
Journal of Clinical Immunology (2023) Vol. 43, Iss. 5, pp. 921-932
Open Access | Times Cited: 16
Life-threatening COVID-19 in a thymoma patient with anti-interferon-α autoantibodies
Y. Shih, Wan-Ting Tsai, Bei‐Chia Guo, et al.
Journal of Microbiology Immunology and Infection (2025)
Open Access
Impact long COVID on self-reported disease activity, disability, and quality of life in individuals with inflammatory arthritis
Zachary S. Wallace, Lin Miao, Shruthi Srivatsan, et al.
Seminars in Arthritis and Rheumatism (2025) Vol. 71, pp. 152657-152657
Closed Access
Autoantibodies to Interferons in Infectious Diseases
Eugenia Quirós-Roldán, Alessandra Sottini, Simona Signorini, et al.
Viruses (2023) Vol. 15, Iss. 5, pp. 1215-1215
Open Access | Times Cited: 14
No link between type I interferon autoantibody positivity and adverse reactions to COVID-19 vaccines
Ahmet Yalçınkaya, Marco Cavalli, Axel Cederholm, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 4
Human determinants of age-dependent patterns of death from infection
Laurent Abel, Jean‐Laurent Casanova
Immunity (2024) Vol. 57, Iss. 7, pp. 1457-1465
Open Access | Times Cited: 4
Incontinentia pigmenti underlies thymic dysplasia, autoantibodies to type I IFNs, and viral diseases
Jérémie Rosain, Tom Le Voyer, Xian Liu, et al.
The Journal of Experimental Medicine (2024) Vol. 221, Iss. 11
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top